Leonardo M. R. Ferreira

Medical University of South Carolina — United States

Medicine · Health Sciences

23h-index3.3kcitations83works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(28), T-cell and B-cell Immunology(22), Immune Cell Function and Interaction(21), Reproductive System and Pregnancy(8), CRISPR and Genetic Engineering(7)

Publications83 total

Why regulatory T cells love lactic acid
Molecular Therapy — Methods & Clinical Development·2025Open Access
A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemia
Blood Cancer Journal·2025Open Access
Genome-wide CRISPR-Cas9 knockout screen identifies essential genes and pathways for HLA-G expression in extravillous trophoblast 4327
The Journal of Immunology·2025Open Access
Chimeric anti-HLA antibody receptor engineered human regulatory T cells (CHAR Tregs) suppress alloreactive B cells from pre-sensitized transplant recipients 9218
The Journal of Immunology·2025Open Access
From rough to refined: Applying diamond standards to CAR Treg development
Molecular Therapy — Methods & Clinical Development·2025Open Access
Editorial: Repurposing cancer immunotherapies for use in autoimmunity and transplantation
Frontiers in Immunology·2025Open Access
Autoimmune diabetes and targets for immunomodulation
Seminars in Immunology·2025· 1 cited
Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipients
Frontiers in Immunology·2025· 1 citedOpen Access
Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative
Diabetes·2025Open Access
Nutrition and Gut Microbiota–Immune System Interplay in Chronic Diseases
Nutrients·2025· 3 citedOpen Access
Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair
2025· 3 citedOpen Access
Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipients
2025Open Access
The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts
Proceedings of the National Academy of Sciences·2025· 6 citedOpen Access
Expanding the engineered Treg multiverse
Molecular Therapy·2025· 3 cited
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells
Scientific Reports·2025· 10 citedOpen Access
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Journal of Visualized Experiments·2025· 5 citedOpen Access
High-affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells
Molecular Therapy — Methods & Clinical Development·2024· 17 citedOpen Access
Combinatorial genetic engineering strategy for immune protection of stem cell-derived beta cells by chimeric antigen receptor regulatory T cells
Cell Reports·2024· 26 citedOpen Access
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells
2024Open Access
Combinatorial genome engineering strategy for CAR-Treg antigen-specific immune protection of stem cell-derived cells
The Journal of Immunology·2024
page 1 of 5Next →

Frequent Co-authors

Qizhi Tang(9), Torsten Meißner(8), Yannick D. Müller(8), Jeffrey A. Bluestone(6), Jack L. Strominger(6), Rob A. Robino(6), Ana M. Urbano(6), Chad A. Cowan(5), Nikolaos Skartsis(5), Maria Carmen Alpoim(5), Mohammed A. Mostajo-Radji(5), Russell W Cochrane(5), Patrick Ho(4), James A. Wells(4), Patrícia L. Abreu(4), Tamara Tilburgs(3), Justin Eyquem(3), Émilie Ronin(3), Vinh Nguyen(3), Anupurna M. Kaul(3)